Corporate Board Profile
Tech Score: 20/100
2 mention(s) identify PHILLIP A. SHARP, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | 2021-04-02 | Dr. Sharp is an Institute Professor at the David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), and was the Founding Director of the McGovern Institute for Brain Research at MIT. Dr. Sharp has been a professor at MIT since 1974. | Dr. Sharp is a leading researcher in molecular biology and biochemistry with a strong scientific background, including being a professor at MIT and a Nobel Prize winner, indicating strong technical and scientific skills that likely include programming or related expertise. |
| ALNYLAM PHARMACEUTICALS, INC. | 2022-04-05 | Dr. Sharp is a scientific founder of Alnylam and has served as a member of our board of directors since June 2002. Dr. Sharp is an Institute Professor at MIT, and was the Founding Director of the McGovern Institute for Brain Research at MIT. | Dr. Sharp is a leading researcher in molecular biology and biochemistry, a professor at MIT, and has scientific expertise that includes fundamental understanding of core scientific principles, indicating strong technical skills including programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-24 | Dr. Sharp is an Institute Professor at the David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), and was the Founding Director of the McGovern Institute for Brain Research at MIT. Dr. Sharp has been a professor at MIT since 1974. |
| 2014-04-29 | Dr. Sharp is a scientific founder of Alnylam and has served as a member of our board of directors since June 2002. Dr. Sharp is an Institute Professor at MIT and a leading researcher in molecular biology and biochemistry. |
| 2015-03-10 | Dr. Sharp is an Institute Professor at the David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), and was the Founding Director of the McGovern Institute for Brain Research at MIT. |
| 2016-03-17 | Dr. Sharp is a scientific founder of Alnylam and has served as a member of our board of directors since June 2002. Dr. Sharp is an Institute Professor at the David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), and was the Founding Director of the McGovern Institute for Brain Research at MIT. Dr. Sharp has been a professor at MIT since 1974. |
| 2017-03-17 | Dr. Sharp, a leading researcher in molecular biology and biochemistry, brings to our board a fundamental understanding of the core scientific principles of our business. Dr. Sharp received the Nobel Prize for Physiology or Medicine in 1993. |
| 2019-03-21 | Dr. Sharp, a leading researcher in molecular biology and biochemistry, brings to our board a fundamental understanding of the core scientific principles of our business. |
| 2020-03-23 | Dr. Sharp, a leading researcher in molecular biology and biochemistry, brings to our board a fundamental understanding of the core scientific principles of our business. |
| 2021-04-02 | Dr. Sharp is an Institute Professor at the David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), and was the Founding Director of the McGovern Institute for Brain Research at MIT. Dr. Sharp has been a professor at MIT since 1974. |
| 2022-04-05 | Dr. Sharp is a scientific founder of Alnylam and has served as a member of our board of directors since June 2002. Dr. Sharp is an Institute Professor at MIT, and was the Founding Director of the McGovern Institute for Brain Research at MIT. |
| 2023-04-03 | Dr. Sharp, a leading researcher in molecular biology and biochemistry, brings to our board a fundamental understanding of the core scientific principles of our business. |
Data sourced from SEC filings. Last updated: 2026-02-03